Health
FDA approves allergy drug to lessen severity of reactions to peanuts, dairy, other foods
Food allergy sufferers have a new weapon in their fight against severe symptoms.
The U.S. Food and Drug Administration (FDA) has given the injectable Xolair (omalizumab) the green light for use in decreasing the risk of life-threatening reactions to certain foods.
Xolair was approved for “immunoglobulin E-mediated food allergy in certain adults and children 1 year or older,” the FDA announced on Feb. 16.
This is the first medication the FDA has approved to reduce allergic reactions after accidental exposure to several types of food, the agency stated.
GLUTEN-FREE LIFESTYLE: DEBUNKING MYTHS AND DECIDING IF THE DIET IS RIGHT FOR YOU
Robert A. Wood, M.D., was the principal investigator of the multicenter study that led to the FDA approval.
“Treatment options, aside from strict avoidance, have been very limited for the millions of Americans with severe food allergies,” Wood, director of the Division of Pediatric Allergy, Immunology and Rheumatology at Johns Hopkins University School of Medicine in Baltimore, Maryland, told Fox News Digital.
“The lives of these patients and their families are often consumed by fear of accidental exposure to food allergens — and even with strict avoidance, accidental exposures are common.”
“The approval of Xolair for the treatment of food allergy will be very meaningful, and potentially even life-changing, for people with food allergies,” Wood added.
HERE’S WHY YOU’RE BLOATED — AND WHAT TO DO ABOUT THE COMMON DIGESTIVE CONDITION
Kenneth Mendez, president and CEO of the Asthma and Allergy Foundation of America (AAFA), a nonprofit headquartered in Maryland, was not involved in the medication research but spoke with Fox News Digital about the recent approval.
“The stress of living with food allergies can weigh heavily on people and their families, particularly when navigating events like children’s birthday parties, school lunches and holiday dinners with friends and family,” Mendez said.
“Given the growing prevalence of food allergies, this news offers hope to the many children and adults who may benefit from a new way to help manage their food allergies.”
Individuals must still avoid foods they’re allergic to, even if they take Xolair, the FDA noted in the announcement.
“This newly approved use for Xolair will provide a treatment option to reduce the risk of harmful allergic reactions among certain patients with IgE-mediated food allergies,” Kelly Stone, M.D., PhD, associate director of the Division of Pulmonology, Allergy and Critical Care in the FDA’s Center for Drug Evaluation and Research, said in an FDA news release.
“While it will not eliminate food allergies or allow patients to consume food allergens freely, its repeated use will help reduce the health impact if accidental exposure occurs.”
Risk reducer, not cure
Xolair, made by Genentech in California, is not approved for the immediate emergency treatment of allergic reactions. It is also not a substitute for current emergency treatments, the federal agency stated.
Such emergency treatments include doses of epinephrine and EpiPens to prevent anaphylaxis, which is a severe allergic reaction that can potentially be fatal, health experts told Fox News Digital.
Nearly 6% of U.S. adults and children suffer from food allergies, according to the Centers for Disease Control and Prevention (CDC) — and more than 40% of children with food allergies in the U.S. have been treated in the emergency department.
Dr. Fred Davis, associate chair of emergency medicine at Northwell Health in New Hyde Park, New York, said he sees a number of allergic reactions from exposure to food.
“This drug may be able to lower that risk,” he told Fox News Digital.
“Remember that this is a preventative drug, not a medication to be used after exposure when one is having an acute allergic reaction,” Davis cautioned.
“This news offers hope to the many children and adults who may benefit from a new way to help manage their food allergies.”
“The recent FDA approval of Xolair for food allergies marks another important step forward for the 33 million Americans living with this condition,” Dr. Susan Schuval, chief of the Division of Pediatric Allergy/Immunology at Stony Brook Children’s Hospital on Long Island, New York, told Fox News Digital.
“Although Xolair is not a cure for food allergies, its use may lessen the risk of severe reactions from accidental food exposures. Patients will still need to practice food avoidance and carry epinephrine injectors,” Schuval said.
As there is currently no cure for food allergies, the CDC recommends strict avoidance of any foods that cause them.
Milk, eggs, fish, crustacean shellfish, wheat, soy, peanuts, and tree nuts account for the most serious allergic reactions in the U.S., per the agency.
IgE-mediated food allergies — the most severe — occur when the body’s immune system mistakenly perceives a food particle as a harmful invader.
AVOID THESE FAD DIETS IN 2024; TRY THESE HEALTHY METHODS OF EATING INSTEAD
A type of antibody called immunoglobulin E (IgE) contributes to the immune response, which can include stomach issues, itching, hives or anaphylaxis, according to several health experts.
Xolair helps dampen this immune response by targeting certain receptors in the body.
“It is an injection that works on blocking IgE, reducing the risk of an allergic reaction, but needs to be taken regularly to work,” Davis told Fox News Digital.
Research behind the approval
The FDA’s approval decision was based on a study that explored the effectiveness and safety of Xolair in 168 participants ranging from babies to adults.
All participants were allergic to peanuts and at least two other foods, which included milk, wheat, egg, walnut, hazelnut or walnut.
Participants received either Xolair or a placebo for 16 to 20 weeks.
Sixty-eight percent of those who received Xolair were able to tolerate the equivalent of 2½ peanuts without a moderate or severe allergic reaction, compared to 6% who took the placebo.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Also among the participants who received the Xolair injections, 67% of people with egg allergies, 66% of people with milk allergies and 42% of people with cashew allergies were able to consume a single dose (1,000 milligrams or greater) of cashew, milk or egg protein without moderate to severe allergic symptoms.
The agency recommended that an individual should only start the medication in a health care setting equipped to manage anaphylaxis.
Patients should discuss with their health care provider whether Xolair is the right choice for them, experts said.
Fox News Digital reached out to the FDA for additional comment.
For more Health articles, visit www.foxnews.com/health.
Health
7 important health stories you might have missed this week: Catch up here
Every day of the week, Fox News Digital publishes a range of health pieces to keep you up-to-date on the most important wellness news.
We cover cutting-edge medical research, breakthrough medications, mental health challenges, personal medical dramas and more.
In case you missed them, here are a few of our biggest health stories from this week.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
You can see a full list of recent health pieces at http://www.foxnews/health.
1. Hunger could be tied to sleep, expert says
If you’re feeling hungrier than usual lately, your sleep routine could be the culprit. A nutritional biologist offers tips for regulating sleep and curbing unhealthy cravings. Click here to get the story.
2. Health agencies issue bird flu update: ‘Alert, not alarmed’
The CDC and WebMD teamed up this week to deliver an hour-long update on Thursday about the current bird flu outbreak. Fox News Digital breaks down the most important points. Click here to get the story.
3. Melanoma patients share their stories
For Skin Cancer Awareness Month, two melanoma patients are speaking up about their symptoms, treatment and prevention tips to help others avoid the potentially deadly disease. Click here to get the story.
4. Report reveals staggering discrepancy in health care costs
Patients with private health insurance could be charged up to 300% more than those with Medicare, a new report reveals. Doctors explain the reasons for the sticker shock. Click here to get the story.
5. Pastor shares important message about depression
A Dallas pastor who fought his own depression battle shares how he overcame the disease – and why it’s so important for those in church leadership to seek help when they need it. Click here to get the story.
6. Nurse’s depression is cured through breakthrough tech
A Chicago nurse struggled with COVID-19-related PTSD and depression for years until electrical brain tapping therapy finally gave her a new lease on life. Click here to get the story.
7. Young vaper shares warning after nearly dying
A 22-year-old man in Nebraska required a double lung transplant due to vaping. Jackson Allard shares his story as a cautionary tale. “I had a 1% chance to live,” he said. Click here to get the story.
For more Health articles, visit www.foxnews.com/health.
Health
Introducing Our Product Reviews Team, and How We Review | Woman's World
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Forgot your password?
Get back to the Sign In
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Health
What You Should Know About the Military Diet: Experts Weigh In | Woman's World
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Forgot your password?
Get back to the Sign In
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
-
World1 week ago
India Lok Sabha election 2024 Phase 4: Who votes and what’s at stake?
-
News1 week ago
Skeletal remains found almost 40 years ago identified as woman who disappeared in 1968
-
Politics1 week ago
US Border Patrol agents come under fire in 'use of force' while working southern border
-
Politics1 week ago
Tales from the trail: The blue states Trump eyes to turn red in November
-
World1 week ago
Borrell: Spain, Ireland and others could recognise Palestine on 21 May
-
World1 week ago
Catalans vote in crucial regional election for the separatist movement
-
World1 week ago
Europe matters to consumers, and so does your vote
-
Politics1 week ago
North Dakota gov, former presidential candidate Doug Burgum front and center at Trump New Jersey rally